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APOE Gene ε4 Allele Accelerates the Atrophy of
the Inferior Temporal Lobe in Alzheimer's Disease
The apolipoprotein E (APOE) gene ε4 allele is a genetic risk factor for late-onset familial and sporadic Alzheimer's
disease (AD). The change in size of the whole brain or total ventricular system did not differ significantly among
APOE genotypes. The patients with ε3/ε4 or ε4/ε4 genotype (ε4+ group), however, exhibited severe atrophy in
the inferior temporal lobe, while those with ε3/ε3 genotype (ε4- group) showed mild atrophy. Regional cerebral
blood flow (rCBF) in the cerebral cortex, particularly in the temporal lobe, was lower in the ε4+ group than in
the ε4- group. These results indicate that possession, and thus expression, of the APOE ε4 allele preferentially
affects the inferior temporal lobe, encompassing the hippocampus and amygdala, in AD patients.
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Scope of research
This laboratory was founded in 1994 with the aim of linking (bio)chemical research and clinical medicine. Thus, the scope of
our research encompasses the structure, function and regulation of various biomolecules, the pathophysiological significance
of bioreactions in relation to human diseases, and the application of molecular techniques to clinical diagnosis and therapy.
Our current interest is focused on poly(ADP-ribosyl)ation, nuclear (de)localization of proteins in association with apoptosis,










   Alzheimer’s disease (AD) is the most prevalent
neurodegenerative disorder in senescence presenting as
progressive dementia. It is pathologically characterized
by βA4 amyloid deposition in senile plaque cores and
cerebral vessels. In our previous study on Japanese
sporadic AD patients [1], we confirmed the association
between apolipoprotein E (APOE) gene ε4 allele and late-
onset AD. In the present study, we approached the issue
of how APOE genotype affects the progression of the
disease by analyzing AD brains with X-ray computed
tomography (CT), magnetic resonance imaging (MRI) and
Xe-133 single photon emission CT (SPECT) [2].
I. X-ray CT Findings and APOE Genotypes
   We estimated the whole brain atrophy and ventricular
dilatation by using X-ray CT. A comparison between
control and AD revealed a significant difference in the
size of the cerebral hemispheres and ventricular systems.
However, there was no significant difference in these areas
among AD subgroups of different APOE genotypes. A
retrospective study revealed that the progress of cerebral
atrophy along the clinical course was not significantly
faster in patients with ε3/ε4 or ε4/ε4 genotype than in
those with ε3/ε3 genotype. Thus the ε4 allele does not
appear to accelerate atrophy of the brain as a whole in the
course of the disease.
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II. MRI Findings and APOE Genotypes
    We focused further analysis on the inferior temporal
lobe, including the hippocampus and amygdala. This
region is known to be severely affected in AD and
responsible for memory impairment and cognitive decline.
MRI allowed clear visualization of this region. As a
distinct finding, AD patients with ε3/ε4 or ε4/ε4 genotype
exhibited severe atrophy in this region, while those with
ε3/ε3 showed milder atrophy (Figure 1). Atrophy of this
region accompanied dilatation of the temporal horn of the
lateral ventricle. The atrophic change in the inferior
temporal lobe was more marked on the medial side, which
encompasses the limbic system, such as the hippocampus
and amygdala. We analyzed the association of the size of
this region with APOE genotypes and found a difference
among AD subgroups (Figure 2). These results indicate
that the APOE ε4 allele promotes atrophic change in the
brain preferentially in the inferior temporal lobe.
Figure 2.  Infero-medial temporal index (IMTI) of control
subjects and AD patients. The patients were classified into
subgroups of CDR (Clinical Dementia Rating) 2 (moderate) and
CDR 3-5 (severe) with APOE genotype, ε4- or ε4+.
* p < 0.05, as compared with the ε4- group (unpaired t test).
Figure 1. Findings of MRI at the level of the pons. No atrophy
was observed in the inferior temporal lobe of the control subject
(A). Patients with ε3/ε3 (B), ε3/ε4 (C) and ε4/ε4 (D) genotypes
showed mild, moderate or severe atrophy, respectively.
III. Xe-133 SPECT Findings and APOE Genotypes
   In addition to the morphological analysis by X-ray CT
and MRI, we assessed a functional change of AD brain
by Xe-133 SPECT. The mean value of the regional
cerebral blood flow (rCBF) was significantly lower in AD
than in control in all cerebral regions except for the
occipital lobe. Among the AD subgroups, the rCBF was
lower in patients with ε3/ε4 or ε4/ε4 genotype than those
with ε3/ε3; the difference was statistically significant in
the temporal lobe. In view of the fact that rCBF reflects a
functional activity of the brain, the reduction of rCBF
indicates an impaired brain function. A reduction of rCBF
might be caused by the deposition of vascular amyloid,
which was reported to be severe in patients with the APOE
ε4 allele.
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